Professor Paul McNally (IMAGE)

RCSI

Professor Paul McNally

Caption

Professor Paul McNally, Associate Professor of Paediatrics at RCSI, Respiratory Consultant in Children's Health Ireland and lead researcher on the RECOVER study is pictured at the launch of a new €3m study, led by RCSI, to investigate the real-world effects of a new cystic fibrosis medication. Researchers at RCSI University of Medicine and Health Sciences are leading the international research project, called RECOVER, to look at how a new triple combination cystic fibrosis drug, Kaftrio, will affect people in their day to day lives. The project has been awarded €2.85 m from Cystic Fibrosis Foundation (US), €112 thousand from Cystic Fibrosis Trust (UK) and €100 thousand from Cystic Fibrosis Ireland.

Credit

Julien Behal Photography

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.